CN1622806A - 用于治疗膀胱活动过度的方法 - Google Patents

用于治疗膀胱活动过度的方法 Download PDF

Info

Publication number
CN1622806A
CN1622806A CNA028266005A CN02826600A CN1622806A CN 1622806 A CN1622806 A CN 1622806A CN A028266005 A CNA028266005 A CN A028266005A CN 02826600 A CN02826600 A CN 02826600A CN 1622806 A CN1622806 A CN 1622806A
Authority
CN
China
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
butyl
dichlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028266005A
Other languages
English (en)
Chinese (zh)
Inventor
R·比亚韦茨基
C·丹茨曼
K·赫尔措格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1622806A publication Critical patent/CN1622806A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
CNA028266005A 2001-11-02 2002-11-01 用于治疗膀胱活动过度的方法 Pending CN1622806A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE01036680 2001-11-02
SE0103668A SE0103668D0 (sv) 2001-11-02 2001-11-02 Method for the treatment of overactive blader

Publications (1)

Publication Number Publication Date
CN1622806A true CN1622806A (zh) 2005-06-01

Family

ID=20285870

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028266005A Pending CN1622806A (zh) 2001-11-02 2002-11-01 用于治疗膀胱活动过度的方法

Country Status (13)

Country Link
US (1) US20040248914A1 (enExample)
EP (1) EP1450805A1 (enExample)
JP (1) JP2005511561A (enExample)
KR (1) KR20050042211A (enExample)
CN (1) CN1622806A (enExample)
BR (1) BR0213776A (enExample)
CA (1) CA2465140A1 (enExample)
IL (1) IL161599A0 (enExample)
MX (1) MXPA04004071A (enExample)
NO (1) NO20042139L (enExample)
SE (1) SE0103668D0 (enExample)
WO (1) WO2003037341A1 (enExample)
ZA (1) ZA200403199B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107854511A (zh) * 2016-09-21 2018-03-30 惠众生技股份有限公司 关刀豆在制备用于保护膀胱避免损伤的药物中的用途

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121389A1 (en) * 2005-05-10 2006-11-16 Astrazeneca Ab Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300218B (enExample) * 1960-11-08 1968-04-22 Recip Ab
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9505084D0 (en) * 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
GB9922519D0 (en) * 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB9826941D0 (en) * 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107854511A (zh) * 2016-09-21 2018-03-30 惠众生技股份有限公司 关刀豆在制备用于保护膀胱避免损伤的药物中的用途
CN107854511B (zh) * 2016-09-21 2021-02-23 伟翔生技开发股份有限公司 关刀豆在制备用于保护膀胱避免损伤的药物中的用途

Also Published As

Publication number Publication date
ZA200403199B (en) 2005-02-09
CA2465140A1 (en) 2003-05-08
IL161599A0 (en) 2004-09-27
MXPA04004071A (es) 2004-09-06
SE0103668D0 (sv) 2001-11-02
EP1450805A1 (en) 2004-09-01
KR20050042211A (ko) 2005-05-06
NO20042139L (no) 2004-06-25
US20040248914A1 (en) 2004-12-09
BR0213776A (pt) 2004-11-09
WO2003037341A1 (en) 2003-05-08
JP2005511561A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
CN1092643C (zh) 用于增强记忆的氨甲基苯基咪唑衍生物
CN1042029C (zh) 1,4－(二苯基烷基)哌嗪衍生物及含有它的药物组合物
JP4299139B2 (ja) 代謝型グルタミン酸受容体−５のヘテロアリール置換トリアゾールモジュレータ
CN1287487A (zh) 氨基苯氧基乙酸衍生物和含有它们的药用组合物
CN1589269A (zh) 杂1,2－二氢化茚:一类新型有效的大麻配体
CN1284066A (zh) 对α2B或2B/2C肾上腺素能受体具有激动剂样活性的取代咪唑衍生物
CN1049336C (zh) 异恶唑衍生物在制备治疗肠应激综合征的组合物中的用途
CN1374865A (zh) 用于治疗咳嗽的nociceptin受体ORL－1激动剂
CN1956987A (zh) 杂环化合物及其作为醛固酮合酶抑制剂的应用
CN1183129C (zh) 作为加压素激动剂的稠合氮杂�
CN1269719A (zh) 调节性活力的芳酰基哌嗪
CN1956978A (zh) 作为肥大细胞类胰蛋白酶抑制剂的[4－(5－氨基甲基－2－氟－苯基) －哌啶－1－基] －(4－溴－3－甲基－5－丙氧基－噻吩－2－基)-甲酮盐酸盐
CN1568321A (zh) 新的取代4－苯基－4－(1H－咪唑－2－基)－哌啶衍生物及其作为选择性非肽δ－类鸦片激动剂的用途
CN1652787A (zh) 利用δ阿片受体促效药来防止下泌尿系功能障碍的组合物和方法
CN1198820C (zh) N－取代的氮杂环化合物
CN1023010C (zh) 4-杂五环-4-[n-(苯基)酰氨基]哌啶衍生物的制备方法
EA011635B1 (ru) Новые производные амида гетероциклической карбоновой кислоты
CA2770766C (en) Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones
CN86103227A (zh) 制备2-吡咯烷酮衍生物的方法
CN1249059C (zh) 新型哌啶羧酸酰胺衍生物、其制备方法以及含有它们的药物组合物
CN1622806A (zh) 用于治疗膀胱活动过度的方法
CN1610676A (zh) 用于治疗膀胱活动过度的化合物和方法
HK1076732A (en) Method for the treatment of overactive bladder
CN1111988A (zh) 取代的芳族甾类化合物控制生育力的用途及其药物组合物
HK1075658A (en) Compounds and method for the treatment of overactive bladder

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1076732

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1076732

Country of ref document: HK